X-48478122-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_012280.4(FTSJ1):c.75C>T(p.Ser25=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000306 in 1,208,423 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000033 ( 0 hom. 11 hem. )
Consequence
FTSJ1
NM_012280.4 synonymous
NM_012280.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.13
Genes affected
FTSJ1 (HGNC:13254): (FtsJ RNA 2'-O-methyltransferase 1) This gene encodes a member of the methyltransferase superfamily. The encoded protein localizes to the nucleolus, binds to S-adenosylmethionine, and may be involved in the processing and modification of ribosomal RNA. Mutations in this gene are associated with cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant X-48478122-C-T is Benign according to our data. Variant chrX-48478122-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1759727.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.13 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 11 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTSJ1 | NM_012280.4 | c.75C>T | p.Ser25= | synonymous_variant | 2/13 | ENST00000348411.3 | NP_036412.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTSJ1 | ENST00000348411.3 | c.75C>T | p.Ser25= | synonymous_variant | 2/13 | 1 | NM_012280.4 | ENSP00000326948 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00000892 AC: 1AN: 112103Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34271
GnomAD3 genomes
AF:
AC:
1
AN:
112103
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34271
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000128 AC: 23AN: 179392Hom.: 0 AF XY: 0.0000624 AC XY: 4AN XY: 64134
GnomAD3 exomes
AF:
AC:
23
AN:
179392
Hom.:
AF XY:
AC XY:
4
AN XY:
64134
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000328 AC: 36AN: 1096320Hom.: 0 Cov.: 30 AF XY: 0.0000304 AC XY: 11AN XY: 361758
GnomAD4 exome
AF:
AC:
36
AN:
1096320
Hom.:
Cov.:
30
AF XY:
AC XY:
11
AN XY:
361758
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000892 AC: 1AN: 112103Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34271
GnomAD4 genome
AF:
AC:
1
AN:
112103
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34271
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at